KCNJ10 and myeloid sarcoma: Nonetheless, since anti-KIR4.1 autoantibodies were detected at a very low frequency in MS patients, the authors suggest that at least currently serum testing for human KIR4.1-specific antibodies is unlikely to improve the diagnosis of MS in Japanese patients.